Venetoclax联合PD-1阻断剂和Ruxolitinib治疗难治性Epstein-Barr病毒相关性嗜血细胞淋巴组织细胞增多症获得成功。

{"title":"Venetoclax联合PD-1阻断剂和Ruxolitinib治疗难治性Epstein-Barr病毒相关性嗜血细胞淋巴组织细胞增多症获得成功。","authors":"Yue Song, Xiaofei Yang, Qian Wu, Mengxing Xue, Fei Zhou, Depei Wu, Suning Chen, Xuefeng He","doi":"10.1111/bjh.19900","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":135,"journal":{"name":"British Journal of Haematology","volume":" ","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Successful combined venetoclax to PD-1 blockade and ruxolitinib for refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.\",\"authors\":\"Yue Song, Xiaofei Yang, Qian Wu, Mengxing Xue, Fei Zhou, Depei Wu, Suning Chen, Xuefeng He\",\"doi\":\"10.1111/bjh.19900\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":135,\"journal\":{\"name\":\"British Journal of Haematology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2024-11-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Haematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/bjh.19900\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Haematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bjh.19900","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}